How a CDMO Created a Custom Vaccine Development Project

What does it take to move from concept to commercial vaccine manufacturing at speed without compromising quality or compliance? In this conversation, leaders from Alfasigma’s CDMO arm, Morpho, share a detailed look at how they approached a complex vaccine technology transfer, from facility upgrades to regulatory approval. The discussion offers a grounded perspective on execution, coordination, and capability building in today’s evolving CDMO landscape. This podcast explores: • The role of facility design, sterile manufacturing, and cold chain expansion • Why flexibility in equipment and formats matters for biological products • Approaches to contamination control and aseptic processing • Coordinating engineering, quality, and regulatory teams under tight timelines • What this project reveals about broader CDMO trends, from personalization to speed and sustainability